Share Your Insights – Global Thromboprophylaxis Practices in Cancer Care

Dear colleagues,

We invite you to participate in a global survey on thromboprophylaxis practices for patients with cancer receiving ambulatory systemic therapies. This survey aims to understand current practices, assess guideline adherence, and identify gaps in implementation of these strategies. We will also explore the role of pharmacists in optimising cancer-associated thrombosis (CAT) prevention.

Why participate?

Your expertise as a pharmacy practitioner is invaluable in shaping strategies to improve care for patients with cancer. As the questions focus on institutional policies and practices, please discuss with colleagues at your healthcare service to ensure a representative response.

The survey includes optional questions to provide identifying information about yourself, for clarification or to participate in future collaborative initiatives or research in CAT.

Time required: ~15 minutes

Survey link: https://redcap.link/yev4u00d

Deadline: 07 April 2025

This project has received low risk ethics approval by Alfred Health’s HREC to cover researchers from that site. It is also supported by the organisation [BOPA] that has agreed to distribute the survey. Please check at your site for any local ethics or research governance requirements.

Please direct any complaints relating to the conduct of this survey to the Complaints Officer, Office of Ethics and Research Governance, Alfred Health at 03 90763619 or [email protected], quote protocol number 183/25.

This important initiative has been developed in collaboration with oncology pharmacists and is supported by professional oncology organisations worldwide. Your insights will help shape future strategies to enhance evidence-based care for patients at risk of CAT.

We thank you sincerely for your time and contribution!

Regards,

Hadley Bortz ([email protected]) and A/Prof Marliese Alexander ([email protected]) Lead Investigators, on behalf of the global study team

 

Global Study Team

Australia
Hadley Bortz (Alfred Health, Victoria); A/Prof Marliese Alexander, Cheryl Jackson, Bishma Jayathilaka (Peter MacCallum Cancer Centre, Victoria); Simone Taylor (Monash Health, Victoria); Simon Huynh (Northern Health, Victoria); Dr John Coutsouvelis, Maria Larizza (Alfred Health, Victoria); Julianne Chong (Concord Hospital, New South Wales); Courtney Rose (West Moreton Health, Queensland)

Asia
Shinya Suzuki (National Cancer Centre Hospital East, Japan)

Europe
Nick Duncan (Queen Elizabeth Hospital, Birmingham, UK); Netty Cracknell (GenesisCare, UK); Tiene Bauters (Universitair Ziekenhuis Gent, Belgium)

Africa
Winnie Mwangi (Kenyatta University Teaching Referral and Research Hospital, Kenya); Eskinder Ayalew (Tikur Anbessa Specialized Hospital, Ethiopia); Kofi Boamah Mensah (Kwame Nkrumah University of Science and Technology, Komfo Anokye Teaching Hospital, Ghana)

North America
Jennifer Jupp (Alberta Health Services, Canada); Kellie Weddle (Purdue University College of Pharmacy, USA)

South America
Sara Aguayo (Hospital Base San José Osorno, Chile)

Latest News

By BOPA on 2nd April 2026

BOPA welcomes Royal Pharmaceutical Society appointment of Justine Scanlan as Director of Pharmacy

The Royal Pharmaceutical Society (RPS) today (2nd April 2026) announced the appointment of Dr Justine Scanlan FRPharmS as its new Director of Pharmacy, a key leadership role as the organisation…

Read article
By BOPA Research Subcommittee on 30th March 2026

Abstract Submission for #BOPA2026 is NOW OPEN

Abstract Submission for the 29th Annual BOPA Conference 2026 is now OPEN     Delegates are invited to present results of their clinical and technical work as a poster with…

Read article
By Caoimhe Keenan on 29th March 2026

BOPA Education and Training Webinar: Clinical AI in the NHS

Helena Langford is a Fellow in Clinical AI and a Clinical Informatics Pharmacist at University Hospitals Bristol and Weston NHS Foundation Trust, with several years of experience in clinical informatics.…

Read article
By Suriya Marshall on 14th March 2026

Parliamentary Intervention Sparks National Campaign to Protect NHS Staff from Hazardous Medicinal Products (HMPs)

First UK Campaign to Protect Healthcare Workers from Exposure to Hazardous Medicinal Products (HMPs) launches in Westminster London, 10 March 2026: Today, the Safer Healthcare and Biosafety Network (SHBN) launches…

Read article